According to the latest data from the Hong Kong Stock Exchange, on May 14, a shareholder of CARSGEN-B (02171) deposited shares with UBS Securities Hong Kong, with a deposit value of HKD 1.927 billion, accounting for 14.5% of the shares. CARSGEN-B announced that before the trading session on May 15, 2026, the company, the seller Yijie Biotechnology Holdings Limited, and the joint placing agents entered into a placing agreement. Under this agreement, the seller agreed to sell, and the joint placing agents agreed to act as the seller's agents, making their best efforts to facilitate no fewer than six placees to purchase up to 23.7 million placing shares at a placing price of HKD 19.84 per share.